School of Medicine
Showing 1,131-1,140 of 13,047 Results
-
Melissa L Bondy
Stanford Medicine Discovery Professor, Professor of Epidemiology and Population Health and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsPrincipal Investigator, Discovery, Biology and Risk of Inherited Variants in Glioma, 1R01CA217105-01A1, NIH/NCI, 05/01/2018-06/30/2022, MPI (Contact PI)
Principal Investigator, Characterizing Germline and Somatic Alterations by Glioma Subtypes and Clinical Outcome, 1R01CA232754-01, 07/01/2019-06/30/2023, MPI (Contact PI)
Co-Leader (Project), SPORE in Brain Cancer, PI – Fred Lang (Sub with MD Anderson), 2 P50CA127001-11, 09/01/2019-08/31/2023
Co-Investigator, Stanford University Cancer Center, PI – Steve Artandi, P30 CA124435, NCI, 09/15/10-05/31/22
Co-Investigator, Ovarian Cancer Survival in African-American Women, PI, Joellen Schildkraut, R01 CA237318-01A1, NIH/NCI, 07/01/2020-06/31/2025 -
C. Andrew Bonham, MD, FACS
Associate Professor of Surgery (Abdominal Transplantation), Emeritus
Current Research and Scholarly InterestsTolerance induction in liver transplantation.
Hepatocyte transplantation. -
Bernardo Bonilauri
Instructor, Cardiovascular Institute
BioDr. Bernardo Bonilauri is a molecular biologist investigating the fundamental mechanisms of protein misfolding, cryptic peptides, and non-canonical codes in human biology and disease. He completed his postdoctoral training at the Stanford Cardiovascular Institute under the mentorship of Dr. Joseph C. Wu, after which he was appointed Instructor. In this role, he continues to develop advanced in vitro disease models to probe molecular and cellular processes underlying human pathology.
His research focuses on Transthyretin Amyloidosis (ATTR) and related protein misfolding disorders, applying multi-omics, structural biology, and stem cell–based platforms to dissect how pathogenic aggregates form and impair cellular function. In parallel, Dr. Bonilauri investigates microproteins encoded by small open reading frames (sORFs), with emphasis on their translation, subcellular localization, and biological functions in human cells. -
Hector Fabio Bonilla
Clinical Professor, Medicine - Infectious Diseases
BioAs a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
